SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,655.64 |
| Enterprise Value ($M) | 3,435.77 |
| Book Value ($M) | 1,424.96 |
| Book Value / Share | 11.94 |
| Price / Book | 2.57 |
| NCAV ($M) | 1,403.35 |
| NCAV / Share | 11.76 |
| Price / NCAV | 2.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.51 |
| Return on Equity (ROE) | -0.64 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.73 |
| Current Ratio | 15.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,542.29 |
| Assets | 1,563.89 |
| Liabilities | 138.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 10.90 |
| Operating Income | -378.94 |
| Net Income | -322.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -300.87 |
| Cash from Investing | -854.20 |
| Cash from Financing | 1,192.36 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Janus Henderson Group Plc | 5.90 | ||
| 13G/A | Ra Capital Management, L.p. | 5.40 | 28.69 | |
| 13G | Avoro Capital Advisors LLC | 8.30 | ||
| 13G/A | Price T Rowe Associates Inc /md/ | 9.00 | 10.12 | |
| 13G/A | Cowen Financial Products LLC | 0.00 | -100.00 | |
| 13G/A | Bristol Myers Squibb Co | 4.30 | 0.00 | |
| 13G/A | Vanguard Group Inc | 7.84 | 0.00 | |
| 13G | Wellington Management Group Llp | 5.97 | ||
| 13D/A | Rtw Investments, Lp | 25.05 | ||
| 13G/A | Fmr Llc | 14.04 | -2.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 502,150 | 1,354,416 | 37.08 | |
| 403,666 | 1,516,876 | 26.61 | |
| 214,825 | 950,652 | 22.60 | |
| 216,774 | 900,701 | 24.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RAPT – RAPT Therapeutics, Inc. | RCKT – Rocket Pharmaceuticals, Inc. |
| RLAY – Relay Therapeutics, Inc. | RNAC – Cartesian Therapeutics, Inc. |
| RYTM – Rhythm Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io